Pulmonary hypertension

Pulmonary hypertension is a serious cardiovascular condition characterized by abnormally elevated blood pressure within the pulmonary arteries, which are the blood vessels that carry blood from the heart to the lungs. In healthy cats, the pulmonary circulation operates under relatively low pressure compared to the systemic circulation, but when this pressure becomes elevated, it places significant strain on the right side of the heart and can lead to serious complications. While pulmonary hypertension is less commonly diagnosed in cats compared to dogs, it remains an important condition that veterinarians increasingly recognize as diagnostic capabilities improve. This condition can affect cats of any age but is most frequently identified in middle-aged to senior cats, particularly those with underlying heart or respiratory diseases.

The development of pulmonary hypertension in cats typically occurs secondary to other underlying conditions rather than as a primary disease. The most common causes include left-sided heart disease, chronic respiratory conditions, heartworm disease, and blood clots within the pulmonary vessels. When the pulmonary arteries experience chronically elevated pressure, the vessel walls undergo remodeling and thickening, which further exacerbates the condition and creates a cycle of progressive deterioration. The underlying mechanisms involve vasoconstriction, proliferation of smooth muscle cells within the vessel walls, and in some cases, thrombosis or blood clot formation.

The impact of pulmonary hypertension on a cat's health can be substantial and progressively debilitating. As the right ventricle of the heart must work harder to pump blood through the narrowed pulmonary vessels, it eventually becomes enlarged and weakened, leading to right-sided heart failure. Cats with pulmonary hypertension often experience reduced exercise tolerance, difficulty breathing, lethargy, and decreased quality of life. The condition can significantly shorten lifespan if left untreated and may lead to sudden collapse or death in severe cases. Cat owners should be aware that respiratory symptoms in cats should never be ignored, as they may indicate serious underlying conditions.

Treatment of pulmonary hypertension in cats focuses on managing symptoms, reducing pulmonary arterial pressure, and addressing any underlying conditions contributing to the elevated pressure. While there is no cure for pulmonary hypertension, various medications can help improve quality of life and slow disease progression. Early detection through thorough veterinary examination and appropriate diagnostic testing is crucial for the best possible outcomes. Cats diagnosed with pulmonary hypertension require ongoing veterinary care, regular monitoring, and often lifelong medication to manage their condition effectively.

The primary causes of pulmonary hypertension in cats are predominantly secondary in nature, meaning the condition develops as a consequence of other underlying diseases or abnormalities. Left-sided heart disease represents one of the most common causes, as conditions such as hypertrophic cardiomyopathy or mitral valve disease lead to increased pressure backing up into the pulmonary circulation. Chronic respiratory diseases including bronchitis, asthma, and pulmonary fibrosis can also trigger pulmonary hypertension by causing chronic hypoxia, which stimulates vasoconstriction in the pulmonary vessels. Heartworm disease, while less common in cats than dogs, can directly obstruct pulmonary arteries and cause significant pulmonary hypertension. Pulmonary thromboembolism, where blood clots lodge in the pulmonary vessels, represents another important cause of this condition.

Genetic and hereditary factors may play a role in some cases of pulmonary hypertension, particularly when it occurs in younger cats without obvious underlying causes. While primary or idiopathic pulmonary hypertension is rare in cats, genetic predisposition may influence how individual cats respond to various triggers and stressors on the pulmonary vasculature. Certain breeds with predisposition to heart disease may have increased risk of developing secondary pulmonary hypertension. Research into the genetic components of feline pulmonary hypertension remains limited, but family history of cardiac disease should be considered when evaluating affected cats.

Environmental and lifestyle factors can contribute to the development or exacerbation of pulmonary hypertension in cats. Cats living at high altitudes may be exposed to chronic hypoxia, which can stimulate pulmonary vasoconstriction over time. Indoor air quality, exposure to secondhand smoke, and environmental allergens may contribute to chronic respiratory conditions that predispose cats to pulmonary hypertension. Obesity places additional strain on the cardiovascular system and may worsen underlying conditions. Sedentary lifestyle combined with poor nutrition can contribute to overall cardiovascular health decline.

Several risk factors increase a cat's likelihood of developing pulmonary hypertension. Advanced age is a significant risk factor, as older cats are more likely to have accumulated cardiac or respiratory conditions that predispose them to elevated pulmonary pressures. Cats with pre-existing heart disease, particularly hypertrophic cardiomyopathy, are at substantially increased risk. Chronic respiratory conditions, including feline asthma, create ongoing stress on the pulmonary vasculature. Cats that have experienced blood clots or have conditions predisposing to thromboembolism face elevated risk as well.

The mechanism by which pulmonary hypertension develops involves complex interactions between the pulmonary vessels, blood, and surrounding lung tissue. When the pulmonary arteries are exposed to chronically elevated pressures or repeated injury, the smooth muscle cells within the vessel walls begin to proliferate and the walls thicken. This vascular remodeling reduces the internal diameter of the vessels, further increasing resistance to blood flow. The endothelial cells lining the vessels also become dysfunctional, producing less vasodilating substances like nitric oxide while increasing production of vasoconstrictors. This creates a self-perpetuating cycle where increased pressure leads to vascular changes that further elevate pressure, eventually leading to right heart failure if left untreated.

Early warning signs of pulmonary hypertension in cats are often subtle and may be easily overlooked by owners. Cats are notorious for hiding illness, and the initial symptoms of pulmonary hypertension can be vague and nonspecific. Owners may first notice slightly decreased activity levels or a reluctance to engage in normal play activities. Mild exercise intolerance may manifest as the cat tiring more quickly during activity or resting more frequently. Some cats may show subtle changes in breathing patterns that are only noticeable during close observation. A slight increase in respiratory rate at rest or minimal effort-induced breathing changes may be the earliest detectable signs. These early symptoms often develop gradually over weeks to months, making them easy to attribute to normal aging or dismiss entirely.

Common symptoms of pulmonary hypertension become more apparent as the condition progresses and include respiratory signs that become increasingly difficult to ignore. Affected cats frequently develop tachypnea, or rapid breathing, even at rest. Labored breathing with increased abdominal effort may become noticeable, and some cats adopt an orthopneic posture with neck extended and elbows abducted to ease breathing. Coughing, while less common in cats than dogs with pulmonary hypertension, may occur in some cases. General weakness and lethargy become more pronounced, and owners often report that their cat simply seems tired all the time. Exercise intolerance progresses to the point where even minimal activity causes respiratory distress.

Behavioral changes associated with pulmonary hypertension can provide important clues for observant owners. Cats may become less social and prefer to rest in quiet, secluded areas. Activity levels typically decrease significantly, with affected cats spending more time sleeping and showing little interest in toys or play. Appetite changes are common, with some cats eating less due to fatigue or respiratory discomfort during eating. Water intake may increase or decrease depending on concurrent conditions. Litter box habits may change as cats become reluctant to exert the effort required to reach the box or cover waste. Some cats may vocalize more, particularly if experiencing discomfort or distress.

Physical signs observable during examination include several characteristic findings. Cats may display cyanosis, a bluish discoloration of the gums, tongue, or skin, indicating inadequate oxygenation. The mucous membranes may appear pale rather than pink and healthy. In cases where right-sided heart failure has developed, abdominal distension due to fluid accumulation may be visible. Some cats develop peripheral edema, though this is less common than in dogs. Weight loss may become apparent as the condition progresses and appetite decreases. The cat's coat may appear dull and unkempt due to decreased grooming behavior related to fatigue or respiratory difficulty.

Symptom progression in pulmonary hypertension typically follows a pattern of gradual worsening punctuated by acute episodes. As the right side of the heart struggles against increased pulmonary pressure, symptoms of right-sided heart failure begin to emerge. Ascites, or fluid accumulation in the abdomen, may develop and cause visible abdominal distension. Pleural effusion, fluid around the lungs, can cause sudden worsening of respiratory symptoms. The progression from compensated disease to decompensated heart failure can occur gradually or suddenly, depending on the underlying cause and presence of complicating factors. Some cats experience relatively stable periods followed by sudden decline.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with open-mouth breathing, collapse or fainting episodes, profound weakness or inability to stand, severe cyanosis with blue or gray gums, and acute abdominal distension. Syncope, or fainting, occurs when the heart cannot pump adequate blood to the brain during periods of increased demand. Any episode of collapse, even if the cat recovers quickly, warrants immediate emergency evaluation. Open-mouth breathing in cats is always a serious sign indicating severe respiratory compromise. Sudden inability to use the back legs may indicate thromboembolism, a serious complication of cardiac disease. These emergency symptoms indicate the condition has reached a critical stage requiring immediate medical intervention.

The initial veterinary examination for suspected pulmonary hypertension involves a comprehensive physical assessment and detailed history taking. The veterinarian will carefully listen to the cat's heart and lungs using a stethoscope, checking for heart murmurs, abnormal heart rhythms, and abnormal lung sounds. A split or accentuated second heart sound may suggest pulmonary hypertension. The veterinarian will assess the cat's respiratory rate and effort, examine the color of mucous membranes, and check for evidence of fluid accumulation. Questions about the cat's activity level, appetite, breathing patterns, coughing, and any episodes of weakness or collapse help establish the timeline and severity of symptoms. Information about pre-existing conditions, medications, and any previous cardiac evaluations is also essential.

Diagnostic testing for pulmonary hypertension involves several imaging and laboratory studies. Echocardiography, or cardiac ultrasound, is the primary diagnostic tool and allows visualization of the heart chambers, valves, and estimation of pulmonary arterial pressures. The echocardiogram can reveal right heart enlargement, abnormal septal motion, and tricuspid regurgitation, which allows estimation of pulmonary pressures using Doppler techniques. Thoracic radiographs provide information about heart size, pulmonary vessel appearance, and lung condition. Blood tests including complete blood count, chemistry panel, and thyroid testing help identify underlying conditions. Additional tests may include blood pressure measurement, electrocardiogram, and testing for heartworm disease. In some cases, advanced imaging such as CT angiography may be recommended.

Differential diagnosis is important because several conditions can cause symptoms similar to pulmonary hypertension. Primary heart diseases such as hypertrophic cardiomyopathy may present similarly and must be distinguished, though they often coexist with pulmonary hypertension. Feline asthma and chronic bronchitis cause respiratory symptoms that overlap with pulmonary hypertension. Pleural effusion from various causes can mimic respiratory signs of pulmonary hypertension. Anemia can cause weakness and exercise intolerance similar to early pulmonary hypertension. The veterinarian systematically rules out or identifies concurrent conditions through appropriate testing, as accurate diagnosis is essential for appropriate treatment planning.

Diagnosis confirmation of pulmonary hypertension relies primarily on echocardiographic findings demonstrating elevated pulmonary arterial pressures. Pulmonary hypertension is typically defined as estimated systolic pulmonary arterial pressure exceeding specific thresholds, with mild, moderate, and severe categories based on pressure measurements. The diagnosis often includes characterization of the underlying cause, as this significantly impacts treatment decisions and prognosis. Once pulmonary hypertension is confirmed, additional testing may be performed to fully characterize any underlying conditions. Results from multiple tests are typically synthesized to provide a complete picture of the cat's cardiovascular status. The veterinarian will discuss findings with the owner, explain the severity of the condition, and outline treatment options and expected outcomes.

Emergency and immediate treatment for cats presenting with severe pulmonary hypertension focuses on stabilization and supportive care. Oxygen supplementation is typically the first intervention for cats in respiratory distress, delivered via oxygen cage, mask, or flow-by methods depending on the cat's tolerance and severity of distress. Stress reduction is critically important, as excitement and anxiety can significantly worsen respiratory compromise in affected cats. Sedation may be necessary for extremely distressed patients. If pleural effusion is present and contributing to respiratory difficulty, thoracocentesis to remove fluid from the chest cavity may provide immediate relief. Diuretic therapy may be initiated to address fluid accumulation. The goal of initial treatment is to stabilize the patient sufficiently for diagnostic workup and long-term treatment planning.

Medical management of pulmonary hypertension in cats involves several categories of medications aimed at reducing pulmonary arterial pressure and supporting cardiac function. Sildenafil, a phosphodiesterase-5 inhibitor, is commonly used to cause pulmonary vasodilation and reduce pulmonary pressures. This medication works by prolonging the action of nitric oxide, a natural vasodilator. Pimobendan, an inodilator medication, may be prescribed to improve cardiac function and cause vasodilation. Diuretics such as furosemide help manage fluid accumulation associated with heart failure. Other medications including ACE inhibitors may be used depending on the specific situation. Treatment of underlying conditions such as heart disease, respiratory disease, or heartworm infection is essential for comprehensive management. Medication dosages require careful adjustment and regular monitoring.

Surgical options for pulmonary hypertension in cats are limited compared to other conditions, as there are no routine surgical interventions that directly address elevated pulmonary pressures. However, surgery may be relevant for treating certain underlying causes. In cases of heartworm disease, surgical extraction of worms from pulmonary vessels has been performed in severe cases, though this is rarely necessary in cats. If pulmonary hypertension is secondary to congenital heart defects, surgical correction of the defect may be possible in some cases at specialized centers. Pericardiocentesis may be needed if pericardial effusion is present. Generally, medical management rather than surgical intervention is the mainstay of treatment for feline pulmonary hypertension.

Supportive care plays an important role in managing cats with pulmonary hypertension. Oxygen therapy at home using an oxygen concentrator may be recommended for cats with chronic hypoxemia. Nutritional support is important, particularly for cats with reduced appetite, and prescription cardiac diets may be recommended. Stress reduction through environmental modification helps prevent acute exacerbations. Pain management may be needed if cats are experiencing discomfort. Maintaining adequate hydration while managing fluid overload requires careful balance. Rest is important, and activity restriction may be necessary during acute episodes or severe disease. Creating a calm, comfortable environment supports overall wellbeing.

Alternative and complementary treatments for pulmonary hypertension in cats have limited evidence but may provide supportive benefits in some cases. Omega-3 fatty acid supplementation may have mild anti-inflammatory and cardiovascular benefits. Antioxidant supplementation has been suggested to support vascular health. Acupuncture has been used in some cases to support overall wellbeing and potentially improve circulation. Herbal supplements should be used with extreme caution and only under veterinary guidance, as many can interact with cardiac medications. Physical therapy is generally not applicable to pulmonary hypertension management. Any complementary approaches should be discussed with the veterinarian to ensure safety and avoid interactions with prescribed medications.

Treatment decisions for pulmonary hypertension depend on multiple factors that must be carefully considered. The severity of pulmonary hypertension and presence of right heart failure significantly influence treatment intensity. Underlying causes must be identified and addressed as part of comprehensive management. The cat's overall health status and presence of concurrent conditions affect medication choices and prognosis. Cost considerations are relevant, as long-term management requires ongoing medication and monitoring expenses. Owner lifestyle and ability to administer medications multiple times daily influences treatment feasibility. Expected outcomes vary significantly based on underlying cause and disease severity, with some cats responding well to treatment while others experience progressive decline despite therapy. Regular communication between owner and veterinarian is essential for adjusting treatment as needed.

Recovery timeline for cats with pulmonary hypertension depends significantly on the underlying cause, severity at diagnosis, and response to treatment. Cats experiencing acute decompensation may show improvement within days to weeks once appropriate treatment is initiated and they are stabilized. However, pulmonary hypertension is generally a chronic, progressive condition requiring ongoing management rather than a condition from which cats fully recover. Initial response to medication typically becomes apparent within the first few weeks of treatment, with improved energy levels and reduced respiratory effort often being the first positive signs. Long-term management focuses on maintaining stability and quality of life rather than achieving cure. Some cats remain stable for months to years with appropriate treatment, while others experience gradual progression despite therapy.

Post-treatment care for cats with pulmonary hypertension involves careful attention to medication administration and monitoring for changes. Owners must administer medications consistently, often multiple times daily, and monitor for side effects. Activity restriction may be recommended, particularly during the initial stabilization period and during any episodes of worsening symptoms. Regular rechecks with the veterinarian are essential to monitor response to treatment and adjust medications as needed. Owners should keep detailed records of respiratory rate at rest, activity levels, appetite, and any concerning symptoms to share with the veterinarian. Dietary management may include sodium restriction and ensuring adequate nutrition. Environmental modifications to reduce stress and ensure easy access to resources support daily management.

Prognosis factors for pulmonary hypertension in cats include the underlying cause, severity of pulmonary pressures at diagnosis, and presence of right heart failure. Cats with mild pulmonary hypertension secondary to treatable conditions may have a better prognosis than those with severe primary pulmonary hypertension or end-stage heart disease. Response to initial treatment provides important prognostic information, with cats showing good response having more favorable outcomes. The development of right heart failure worsens prognosis significantly. Quality of life considerations are important, as some cats maintain good quality of life with appropriate management while others experience progressive debilitation. Age and overall health status also influence prognosis, with younger, otherwise healthy cats potentially tolerating the condition better.

Long-term outlook for cats with pulmonary hypertension requires honest assessment and ongoing adjustment of expectations. While some cats live for extended periods with well-managed pulmonary hypertension, the condition is generally progressive and life-shortening. Regular monitoring through periodic echocardiography helps track disease progression and guides treatment adjustments. Recurrence of severe symptoms despite treatment may indicate disease progression and warrants reassessment of management strategy. Return to completely normal life is unlikely for most cats, but many achieve a good quality of life with appropriate support. Owners should work closely with their veterinarian to establish goals of care and make decisions based on quality of life considerations. End-of-life planning discussions, while difficult, are important as the condition progresses.

Primary prevention of pulmonary hypertension in cats focuses on preventing or effectively managing the conditions that most commonly lead to elevated pulmonary pressures. Since left-sided heart disease is a major cause, early detection and management of cardiac conditions through regular veterinary examinations is important. Heartworm prevention is essential in endemic areas, as heartworm disease can cause severe pulmonary hypertension. Preventing and effectively treating respiratory conditions such as feline asthma may reduce risk. Maintaining healthy body weight reduces overall cardiovascular strain. For cats with known cardiac disease, following veterinary recommendations for monitoring and treatment helps prevent progression to pulmonary hypertension. Genetic screening of breeding cats for hereditary heart conditions may help reduce prevalence in predisposed breeds over time.

Environmental prevention strategies can reduce risk factors for conditions leading to pulmonary hypertension. Maintaining good indoor air quality by avoiding smoking around cats, using air purifiers, and minimizing exposure to dust and irritants supports respiratory health. Reducing environmental stressors helps maintain overall cardiovascular health. Ensuring cats live at appropriate altitudes if predisposed to cardiac conditions may be relevant in some geographic areas. Providing a safe indoor environment prevents injuries and reduces exposure to infectious diseases that could affect heart or lung health. Regular parasite prevention reduces risk of infections that could impact cardiovascular health. Minimizing exposure to toxins and ensuring water quality supports overall health.

Dietary prevention approaches focus on supporting cardiovascular health throughout the cat's life. Feeding a high-quality, balanced diet appropriate for the cat's life stage supports overall health. Avoiding excessive sodium intake may be beneficial for cardiovascular health. Maintaining ideal body weight through appropriate caloric intake and portion control reduces cardiovascular strain. Omega-3 fatty acid supplementation may support cardiovascular health. Ensuring adequate taurine intake is essential for cardiac health in cats. Fresh, clean water should always be available. Consultation with a veterinarian or veterinary nutritionist can help establish the optimal diet for individual cats, particularly those with increased cardiovascular risk.

Health maintenance through regular veterinary care is crucial for preventing pulmonary hypertension and detecting it early when it does occur. Annual or twice-yearly wellness examinations allow veterinarians to detect subtle signs of cardiac or respiratory disease before they progress. Blood pressure monitoring during routine visits helps identify hypertension. Cardiac auscultation can detect murmurs or arrhythmias warranting further evaluation. Routine blood work may reveal conditions predisposing to pulmonary hypertension. Vaccinations prevent infectious diseases that could impact heart or lung health. Dental care prevents infections that could potentially affect the heart. Maintaining records of previous examinations helps track changes over time.

Early intervention when risk factors or early disease is identified provides the best chance of preventing pulmonary hypertension or minimizing its severity. Cats diagnosed with conditions predisposing to pulmonary hypertension should undergo regular cardiac evaluation including echocardiography. Early treatment of heart disease before pulmonary hypertension develops can slow or prevent progression. Addressing respiratory conditions aggressively reduces chronic stress on pulmonary vasculature. Prompt evaluation of any new symptoms such as coughing, breathing changes, or reduced activity allows early detection. Working closely with a veterinarian to establish an appropriate monitoring schedule for at-risk cats is essential. Early referral to a veterinary cardiologist may be beneficial for cats with cardiac disease to optimize management and prevent complications including pulmonary hypertension.

Daily management of a cat with pulmonary hypertension requires establishing consistent routines and careful attention to the cat's needs. Medication administration must occur reliably at prescribed times, which may mean adjusting household schedules to accommodate multiple daily doses. Monitoring respiratory rate at rest by counting breaths while the cat sleeps provides valuable information about disease stability. Maintaining a log of daily observations including activity level, appetite, respiratory effort, and any concerning symptoms helps track trends over time. Feeding should occur in a low-stress environment with food easily accessible, as cats may fatigue during eating. Water should be available in multiple locations to encourage adequate hydration. Litter boxes should be easily accessible with low sides to reduce effort required for use.

Home environment modifications can significantly impact quality of life for cats with pulmonary hypertension. Creating resting areas on ground level reduces the need for jumping and climbing that may cause respiratory distress. Providing elevated resting spots with ramps rather than requiring jumping allows cats to enjoy preferred perches. Temperature and humidity control helps maintain comfortable breathing, as extreme temperatures and low humidity can stress respiratory function. Minimizing household stressors such as loud noises, conflict with other pets, and disruption of routines reduces cardiovascular strain. Ensuring quiet, secluded spaces where the cat can rest undisturbed supports recovery and comfort. Air quality should be optimized by avoiding smoking, minimizing dust, and using air filtration if needed.

Quality of life maintenance focuses on ensuring affected cats can still experience enjoyment and comfort despite their condition. Gentle interaction and affection appropriate to the cat's energy level provides emotional support. Modified play sessions using minimal-exertion activities can provide mental stimulation without overexertion. Comfortable bedding in preferred locations encourages rest. Grooming assistance helps cats maintain coat condition when they are too fatigued for self-grooming. Puzzle feeders at an easy difficulty level can provide mental enrichment. Window perches for bird watching offer stimulation without physical exertion. Maintaining normal household routines as much as possible provides security and reduces stress. The goal is to maximize comfort and enjoyment while respecting the cat's limitations.

Monitoring and ongoing care requires vigilance for changes that may indicate disease progression or complications. Regular veterinary rechecks, typically every three to six months for stable patients, allow assessment of disease status and medication adjustment. Echocardiography is periodically repeated to monitor cardiac changes and pulmonary pressures. Owners should know the signs of acute worsening that require immediate veterinary attention, including sudden respiratory distress, collapse, or severe lethargy. Blood work may be monitored to check organ function, particularly with long-term medication use. Communication with the veterinary team about any observed changes ensures prompt attention to concerning developments. Emergency contact information and plans for after-hours emergencies should be established.

Caregiver support is essential for owners managing a cat with pulmonary hypertension, as the condition can be emotionally and financially demanding. Connecting with online support communities for owners of cats with heart disease provides emotional support and practical tips. Understanding the expected course of the condition helps owners prepare for potential changes and make informed decisions. Financial planning for ongoing medication and veterinary costs reduces stress. Taking breaks and practicing self-care prevents caregiver burnout. Having honest conversations with the veterinary team about prognosis, quality of life, and end-of-life considerations helps owners prepare mentally and emotionally. Recognizing that some days will be harder than others and accepting help when offered supports long-term caregiving sustainability. The bond between owner and cat remains valuable despite the challenges of managing chronic illness.

Pulmonary hypertension in cats is primarily associated with underlying cardiac or respiratory disease rather than specific breed predisposition to pulmonary hypertension itself. However, breeds predisposed to heart disease have indirectly elevated risk. Maine Coon cats have well-documented predisposition to hypertrophic cardiomyopathy, which can lead to secondary pulmonary hypertension. Ragdoll cats are similarly predisposed to hypertrophic cardiomyopathy with associated pulmonary hypertension risk. Persian and Himalayan cats may be at elevated risk due to their brachycephalic anatomy affecting respiratory function and predisposition to cardiac disease. British Shorthairs have recognized increased incidence of hypertrophic cardiomyopathy. Sphynx cats also show breed predisposition to hypertrophic cardiomyopathy. The genetic mutations underlying cardiomyopathy in several of these breeds have been identified, allowing for genetic testing.

Mixed breed cats and other purebred breeds can certainly develop pulmonary hypertension, and breed alone should not determine screening decisions. Senior cats of any breed have increased risk due to the cumulative likelihood of developing cardiac or respiratory conditions with age. Cats with obesity have elevated cardiovascular risk regardless of breed. Cats living in heartworm-endemic areas have increased risk if not receiving preventive medication. Cats with chronic respiratory conditions such as asthma have increased risk over time. Any cat diagnosed with heart disease should be monitored for development of pulmonary hypertension regardless of breed background.

Screening recommendations for pulmonary hypertension focus on cats with identified risk factors rather than breed-based screening for pulmonary hypertension specifically. Cats of breeds predisposed to hypertrophic cardiomyopathy should undergo echocardiographic screening, with recommendations varying by breed but typically starting at one to three years of age and repeated periodically. Genetic testing is available for some breeds to identify carriers of cardiomyopathy mutations. Cats diagnosed with any form of heart disease should be monitored for development of pulmonary hypertension through periodic echocardiography. Annual wellness examinations with cardiac auscultation help detect heart disease early. Breeders of high-risk breeds should participate in cardiac screening programs and avoid breeding affected individuals or known carriers of genetic mutations associated with heart disease.

Conditions commonly co-occurring with pulmonary hypertension include the underlying diseases that often cause elevated pulmonary pressures. Hypertrophic cardiomyopathy is frequently present in cats with pulmonary hypertension, as left heart disease leads to increased pulmonary venous pressure that eventually affects the pulmonary arterial side. Systemic hypertension often coexists, particularly in older cats with kidney disease. Hyperthyroidism may be present concurrently, particularly in senior cats, and can contribute to cardiovascular dysfunction. Chronic kidney disease is common in older cats and often associated with hypertension. Heartworm disease, while less common in cats, can directly cause pulmonary hypertension. Right-sided heart failure frequently develops as a consequence of pulmonary hypertension. Management of pulmonary hypertension must account for these concurrent conditions.

Conditions with symptoms similar to pulmonary hypertension require differentiation through appropriate diagnostic testing. Feline asthma causes respiratory symptoms including coughing and labored breathing that may mimic pulmonary hypertension. Pneumonia presents with respiratory distress and lethargy similar to pulmonary hypertension. Pleural effusion from various causes creates breathing difficulty similar to pulmonary hypertension. Anemia causes weakness and reduced exercise tolerance that overlaps with pulmonary hypertension symptoms. Primary cardiomyopathies without pulmonary hypertension cause many similar symptoms. Mediastinal masses can cause respiratory symptoms resembling pulmonary hypertension. Accurate diagnosis through echocardiography and other testing is essential to distinguish these conditions and provide appropriate treatment.

Potential complications of pulmonary hypertension include progressive right heart failure, which develops as the right ventricle fails against chronically elevated pulmonary pressures. Syncope or fainting episodes may occur during exertion or excitement when cardiac output cannot meet demand. Arrhythmias can develop secondary to cardiac remodeling and may contribute to symptoms or sudden death. Thromboembolism is a feared complication, as cats with cardiac disease are prone to blood clot formation that can lodge in vessels including the aorta. Ascites develops when right heart failure becomes severe. Pleural effusion may develop and worsen respiratory function. Sudden death can occur in severe cases, particularly with exertion or stress. Close monitoring and appropriate treatment help minimize complication risk, though some complications may occur despite optimal management.